Oragenics Enters Into Materials Transfer Agreement With Adjuvance Systems for COVID-19 Vaccine Adjuvant
TAMPA, Fla.--(Business WIRE)--Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) introduced coming into into a substance transfer agreement with...

 
          /cloudfront-us-east-1.images.arcpublishing.com/dmn/3RQGZDVENRDHFDVUU4HSTQYJL4.jpg) 
           
           
           
           
           
           
           
           
           
           
           
           
           
          ![‘[This] must be a crime’ ‘[This] must be a crime’](https://s.yimg.com/ny/api/res/1.2/e75YHCVLKMeyQQ8.8KiWTw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyNDI-/https://itk-assets.nyc3.cdn.digitaloceanspaces.com/2021/01/Screen-Shot-2021-01-11-at-3.16.13-PM-1-1024x908.jpg) 
           
                       
                       
                       
                      